{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:44:37Z","timestamp":1761155077435},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1007\/s11910-001-0104-9","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T15:52:23Z","timestamp":1180108343000},"page":"442-450","source":"Crossref","is-referenced-by-count":20,"title":["Of replications and refutations: The status of Alzheimer\u2019s disease genetic research"],"prefix":"10.1007","volume":"1","author":[{"given":"Lars","family":"Bertram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolph E.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"104_CR1","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","volume":"273","author":"N Risch","year":"1996","unstructured":"Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996, 273:1516\u20131517.","journal-title":"Science"},{"key":"104_CR2","doi-asserted-by":"crossref","DOI":"10.56021\/9780801861406","volume-title":"Analysis of Human Genetic Linkage","author":"J Ott","year":"1999","unstructured":"Ott J: Analysis of Human Genetic Linkage. Baltimore: Johns Hopkins University Press; 1999."},{"key":"104_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/318195","volume":"68","author":"GA Satten","year":"2001","unstructured":"Satten GA, Flanders WD, Yang Q: Accounting for unmeasured population substructure in case-control studies of genetic association using a novel latent-class model. Am J Hum Genet 2001, 68:466\u2013477.","journal-title":"Am J Hum Genet"},{"key":"104_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/85776","volume":"27","author":"L Kruglyak","year":"2001","unstructured":"Kruglyak L, Nickerson DA: Variation is the spice of life. Nat Genet 2001, 27:234\u2013236.","journal-title":"Nat Genet"},{"key":"104_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/nbdi.1996.0016","volume":"3","author":"RE Tanzi","year":"1996","unstructured":"Tanzi RE, Kovacs DM, Kim TW, et al.: The gene defects responsible for familial Alzheimer\u2019s disease. Neurobiol Dis 1996, 3:159\u2013168.","journal-title":"Neurobiol Dis"},{"key":"104_CR6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, et al.: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 1991, 349:704\u2013706.","journal-title":"Nature"},{"key":"104_CR7","unstructured":"AD Mutation Database: http:\/\/molgen-www.uia.ac.be\/AD Mutations. 2001."},{"key":"104_CR8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1411576","volume":"258","author":"GD Schellenberg","year":"1992","unstructured":"Schellenberg GD, Bird TD, Wijsman EM, et al.: Genetic linkage evidence for a familial Alzheimer\u2019s disease locus on chromosome 14. Science 1992, 258:668\u2013671.","journal-title":"Science"},{"key":"104_CR9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng1292-330","volume":"2","author":"P St George-Hyslop","year":"1992","unstructured":"St George-Hyslop P, Haines J, Rogaev E, et al.: Genetic evidence for a novel familial Alzheimer\u2019s disease locus on chromosome 14. Nat Genet 1992, 2:330\u2013334.","journal-title":"Nat Genet"},{"key":"104_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1292-335","volume":"2","author":"C Broeckhoven Van","year":"1992","unstructured":"Van Broeckhoven C, Backhovens H, Cruts M, et al.: Mapping of a gene predisposing to early-onset Alzheimer\u2019s disease to chromosome 14q24.3. Nat Genet 1992, 2:335\u2013339.","journal-title":"Nat Genet"},{"key":"104_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/ng1292-340","volume":"2","author":"M Mullan","year":"1992","unstructured":"Mullan M, Houlden H, Windelspecht M, et al.: A locus for familial early-onset Alzheimer\u2019s disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet 1992, 2:340\u2013342.","journal-title":"Nat Genet"},{"key":"104_CR12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, et al.: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 1995, 375:754\u2013760.","journal-title":"Nature"},{"key":"104_CR13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.286.5441.916","volume":"286","author":"C Haass","year":"1999","unstructured":"Haass C, De Strooper B: The presenilins in Alzheimer\u2019s disease\u2014proteolysis holds the key. Science 1999. 286:916\u2013919.","journal-title":"Science"},{"key":"104_CR14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P, et al.: Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science 1995, 269:973\u2013977.","journal-title":"Science"},{"key":"104_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, et al.: Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 1995, 376:775\u2013778.","journal-title":"Nature"},{"key":"104_CR16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, et al.: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 1999, 398:513\u2013517. First study indicating that the presenilins themselves may actually function as the elusive g-secretases. If proven correct, this finding may have great implications for our understanding of Alzheimer\u2019s disease and also for the development of drugs that act on an etiologic, rather than symptomatic, level.","journal-title":"Nature"},{"key":"104_CR17","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, et al.: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 1993, 43:1467\u20131472.","journal-title":"Neurology"},{"key":"104_CR18","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, et al.: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90:1977\u20131981.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"104_CR19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/302710","volume":"66","author":"Daw E Warwick","year":"2000","unstructured":"Warwick Daw E, Payami H, Nemens EJ, et al.: The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 2000, 66:196\u2013204. First study to actually estimate the number and effect size of the remaining (and as yet unidentified) additional late-onset Alzheimer\u2019s disease (AD) loci on a large sample of families with AD.","journal-title":"Am J Hum Genet"},{"key":"104_CR20","first-page":"1034","volume":"48","author":"MA Pericak-Vance","year":"1991","unstructured":"Pericak-Vance MA, Bebout JL, Gaskell PC, et al.: Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991, 48:1034\u20131050.","journal-title":"Am J Hum Genet"},{"key":"104_CR21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, et al.: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349\u20131356.","journal-title":"JAMA"},{"key":"104_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker D, Haines JL, Rodes L, et al.: ApoE-4 and age at onset of Alzheimer\u2019s disease: the NIMH genetics initiative. Neurology 1997, 48:139\u2013147.","journal-title":"Neurology"},{"key":"104_CR23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/1206","volume":"19","author":"MR Meyer","year":"1998","unstructured":"Meyer MR, Tschanz JT, Norton MC, et al.: APOE genotype predicts when\u2014not whether\u2014one is predisposed to develop Alzheimer disease. Nat Genet 1998, 19:321\u2013322.","journal-title":"Nat Genet"},{"key":"104_CR24","first-page":"A202","volume":"57","author":"AD Roses","year":"1995","unstructured":"Roses AD, Devlin B, Coneally PM, et al.: Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am J Hum Genet 1995, 57(suppl):A202.","journal-title":"Am J Hum Genet"},{"key":"104_CR25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2000.tb05564.x","volume":"924","author":"J Poirier","year":"2000","unstructured":"Poirier J: Apolipoprotein E and Alzheimer\u2019s disease. A role in amyloid catabolism. Ann N Y Acad Sci 2000, 924:81\u201390.","journal-title":"Ann N Y Acad Sci"},{"key":"104_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(94)11100-W","volume":"183","author":"B Nacmias","year":"1995","unstructured":"Nacmias B, Latorraca S, Piersanti P, et al.: ApoE genotype and familial Alzheimer\u2019s disease: a possible influence on age of onset in APP717 Val-->Ile mutated families. Neurosci Lett 1995, 183:1\u20133.","journal-title":"Neurosci Lett"},{"key":"104_CR27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/hmg\/7.9.1511","volume":"7","author":"JC Lambert","year":"1998","unstructured":"Lambert JC, Berr C, Pasquier F, et al.: Pronounced impact of Th1\/E47cs mutation compared with-491 AT mutation on neural APOE gene expression and risk of developing Alzheimer\u2019s disease. Hum Mol Genet 1998. 7:1511\u20131516.","journal-title":"Hum Mol Genet"},{"key":"104_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ng0198-69","volume":"18","author":"MJ Bullido","year":"1998","unstructured":"Bullido MJ, Artiga MJ, Recuero M, et al.: A polymorphism in the regulatory region of APOE associated with risk for Alzheimer\u2019s dementia. Nat Genet 1998, 18:69\u201371.","journal-title":"Nat Genet"},{"key":"104_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/1243","volume":"19","author":"D Blacker","year":"1998","unstructured":"Blacker D, Wilcox MA, Laird NM, et al.: Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998, 19:357\u2013360.","journal-title":"Nat Genet"},{"key":"104_CR30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1997.03550150041033","volume":"278","author":"MA Pericak-Vance","year":"1997","unstructured":"Pericak-Vance MA, Bass MP, Yamaoka LH, et al.: Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997, 278:1237\u20131241.","journal-title":"JAMA"},{"key":"104_CR31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/8.2.237","volume":"8","author":"P Kehoe","year":"1999","unstructured":"Kehoe P, Wavrant-De Vrieze F, Crook R, et al.: A full genome scan for late onset Alzheimer\u2019s disease. Hum Mol Genet 1999, 8:237\u2013245.","journal-title":"Hum Mol Genet"},{"key":"104_CR32","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/7.12.1953","volume":"7","author":"A Liao","year":"1998","unstructured":"Liao A, Nitsch RM, Greenberg SM, et al.: Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer\u2019s disease. Hum Mol Genet 1998, 7:1953\u20131956.","journal-title":"Hum Mol Genet"},{"key":"104_CR33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.49.1.56","volume":"49","author":"DE Kang","year":"1997","unstructured":"Kang DE, Saitoh T, Chen X, et al.: Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer\u2019s disease. Neurology 1997, 49:56\u201361.","journal-title":"Neurology"},{"key":"104_CR34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.55.5.678","volume":"55","author":"MN Koster","year":"2000","unstructured":"Koster MN, Dermaut B, Cruts M, et al.: The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. Neurology 2000, 55:678\u2013684.","journal-title":"Neurology"},{"key":"104_CR35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/bbrc.1999.1295","volume":"264","author":"V Alvarez","year":"1999","unstructured":"Alvarez V, Alvarez R, Lahoz CH, et al.: Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer\u2019s disease. Biochem Biophys Res Commun 1999, 264:48\u201350.","journal-title":"Biochem Biophys Res Commun"},{"key":"104_CR36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.54.2.438","volume":"54","author":"RC Dodel","year":"2000","unstructured":"Dodel RC, Du Y, Bales KR, et al.: Alpha2 macroglobulin and the risk of Alzheimer\u2019s disease. Neurology 2000, 54:438\u2013442.","journal-title":"Neurology"},{"key":"104_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-510X(00)00494-9","volume":"184","author":"JH Jhoo","year":"2001","unstructured":"Jhoo JH, Kim KW, Lee DY, et al.: Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer\u2019s disease in Koreans. J Neurol Sci 2001, 184:21\u201325.","journal-title":"J Neurol Sci"},{"key":"104_CR38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/1531-8249(199909)46:3<382::AID-ANA14>3.0.CO;2-5","volume":"46","author":"L Myllykangas","year":"1999","unstructured":"Myllykangas L, Polvikoski T, Sulkava R, et al.: Genetic association of alpha2-macroglobulin with Alzheimer\u2019s disease in a Finnish elderly population. Ann Neurol 1999, 46:382\u2013390.","journal-title":"Ann Neurol"},{"key":"104_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(00)01758-4","volume":"299","author":"B Nacmias","year":"2001","unstructured":"Nacmias B, Tedde A, Cellini E, et al.: alpha2-Macroglobulin polymorphisms in Italian sporadic and familial Alzheimer\u2019s disease. Neurosci Lett 2001, 299:9\u201312.","journal-title":"Neurosci Lett"},{"key":"104_CR40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(99)00972-6","volume":"279","author":"SN Romas","year":"2000","unstructured":"Romas SN, Mayeux R, Rabinowitz D, et al.: The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics. Neurosci Lett 2000, 279:133\u2013136.","journal-title":"Neurosci Lett"},{"key":"104_CR41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/1531-8249(200009)48:3<400::AID-ANA22>3.0.CO;2-L","volume":"48","author":"P Verpillat","year":"2000","unstructured":"Verpillat P, Bouley S, Hannequin D, et al.: Alpha2-macroglobulin gene and Alzheimer\u2019s disease: confirmation of association by haplotypes analyses. Ann Neurol 2000, 48:400\u2013402.","journal-title":"Ann Neurol"},{"key":"104_CR42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1073\/pnas.97.1.2","volume":"97","author":"J Ott","year":"2000","unstructured":"Ott J: Predicting the range of linkage disequilibrium. Proc Natl Acad Sci U S A 2000, 97:2\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"104_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/303003","volume":"67","author":"ER Martin","year":"2000","unstructured":"Martin ER, Lai EH, Gilbert JR, et al.: SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000, 67:383\u2013394. First study to show that the APOE locus could have been identified through means of association\/linkage-disequilibrium based \u2019finemapping\u2019 (using both individual SNPs as well as haplotypes) without prior knowledge of the common APOE polymorphism.","journal-title":"Am J Hum Genet"},{"key":"104_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1101\/gr.148401","volume":"11","author":"D Fallin","year":"2001","unstructured":"Fallin D, Cohen A, Essioux L, et al.: Genetic analysis of case\/ control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer\u2019s disease. Genome Res 2001, 11:143\u2013151.","journal-title":"Genome Res"},{"key":"104_CR45","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/oxfordjournals.hmg.a018918","volume":"9","author":"JC Lambert","year":"2000","unstructured":"Lambert JC, Goumidi L, Vrieze FW, et al.: The transcriptional factor LBP-1c\/CP2\/LSF gene on chromosome 12 is a genetic determinant of Alzheimer\u2019s disease. Hum Mol Genet 2000, 9:2275\u20132280.","journal-title":"Hum Mol Genet"},{"key":"104_CR46","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0531-5565(00)00193-5","volume":"35","author":"L Bertram","year":"2000","unstructured":"Bertram L, Blacker D, Crystal A, et al.: Candidate genes showing no evidence for association or linkage with Alzheimer\u2019s disease using family-based methodologies. Exp Gerontol 2000, 35:1353\u20131361.","journal-title":"Exp Gerontol"},{"key":"104_CR47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(99)00071-3","volume":"262","author":"A Papassotiropoulos","year":"1999","unstructured":"Papassotiropoulos A, Bagli M, Feder O, et al.: Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer\u2019s disease. Neurosci Lett 1999, 262:171\u2013174.","journal-title":"Neurosci Lett"},{"key":"104_CR48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/1531-8249(200003)47:3<399::AID-ANA22>3.0.CO;2-5","volume":"47","author":"A Papassotiropoulos","year":"2000","unstructured":"Papassotiropoulos A, Bagli M, Kurz A, et al.: A genetic variation of cathepsin D is a major risk factor for Alzheimer\u2019s disease. Ann Neurol 2000, 47:399\u2013403.","journal-title":"Ann Neurol"},{"key":"104_CR49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/geno.1998.5306","volume":"50","author":"GS Zubenko","year":"1998","unstructured":"Zubenko GS, Hughes HB, Stiffler JS, et al.: A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution. Genomics 1998, 50:121\u2013128.","journal-title":"Genomics"},{"key":"104_CR50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0304-3940(99)00635-7","volume":"273","author":"SP McIlroy","year":"1999","unstructured":"McIlroy SP, Dynan KB, McGleenon BM, et al.: Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer\u2019s disease. Neurosci Lett 1999, 273:140\u2013141.","journal-title":"Neurosci Lett"},{"key":"104_CR51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(00)01185-X","volume":"288","author":"TJ Bhojak","year":"2000","unstructured":"Bhojak TJ, DeKosky ST, Ganguli M, et al.: Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer\u2019s disease. Neurosci Lett 2000, 288:21\u201324.","journal-title":"Neurosci Lett"},{"key":"104_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(00)01260-X","volume":"289","author":"FC Crawford","year":"2000","unstructured":"Crawford FC, Freeman MJ, Schinka J, et al.: The genetic association between Cathepsin D and Alzheimer\u2019s disease. Neurosci Lett 2000, 289:61\u201365.","journal-title":"Neurosci Lett"},{"key":"104_CR53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1531-8249(200101)49:1<114::AID-ANA18>3.0.CO;2-M","volume":"49","author":"L Bertram","year":"2001","unstructured":"Bertram L, Guenette S, Jones J, et al.: No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. Ann Neurol 2001, 49:114\u2013116.","journal-title":"Ann Neurol"},{"key":"104_CR54","doi-asserted-by":"crossref","unstructured":"Menzer G, M\u00fcller-Thomsen T, Meins W, et al.: Non-replication of association between cathepsin D genotype and late onset Alzheimer disease. Am J Med Genet 2001, in press.","DOI":"10.1002\/ajmg.1204"},{"key":"104_CR55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s004390050820","volume":"103","author":"Q Hu","year":"1998","unstructured":"Hu Q, Kukull WA, Bressler SL, et al.: The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum Genet 1998, 103:295\u2013303.","journal-title":"Hum Genet"},{"key":"104_CR56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(00)01607-4","volume":"296","author":"SY Guenette","year":"2000","unstructured":"Guenette SY, Bertram L, Crystal A, et al.: Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer\u2019s patients. Neurosci Lett 2000, 296:17\u201320.","journal-title":"Neurosci Lett"},{"key":"104_CR57","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s0089400060587","volume":"6","author":"A Papassotiropoulos","year":"2000","unstructured":"Papassotiropoulos A, Bagli M, Becker K, et al.: No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer\u2019s disease. Int J Mol Med 2000, 6:587\u2013589.","journal-title":"Int J Mol Med"},{"key":"104_CR58","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","volume":"290","author":"L Bertram","year":"2000","unstructured":"Bertram L, Blacker D, Mullin K, et al.: Evidence for genetic linkage of Alzheimer\u2019s disease to chromosome 10q. Science 2000, 290:2302\u20132303.","journal-title":"Science"},{"key":"104_CR59","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1126\/science.290.5500.2303","volume":"290","author":"N Ertekin-Taner","year":"2000","unstructured":"Ertekin-Taner N, Graff-Radford N, Younkin LH, et al.: Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer\u2019s disease pedigrees. Science 2000, 290:2303\u20132304.","journal-title":"Science"},{"key":"104_CR60","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1126\/science.290.5500.2304","volume":"290","author":"A Myers","year":"2000","unstructured":"Myers A, Holmans P, Marshall H, et al.: Susceptibility locus for Alzheimer\u2019s disease on chromosome 10. Science 2000, 290:2304\u20132305.","journal-title":"Science"},{"key":"104_CR61","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","volume":"20","author":"K Vekrellis","year":"2000","unstructured":"Vekrellis K, Ye Z, Qiu WQ, et al.: Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulindegrading enzyme. J Neurosci 2000, 20:1657\u20131665.","journal-title":"J Neurosci"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0104-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-001-0104-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0104-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T01:08:08Z","timestamp":1683853688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-001-0104-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1007\/s11910-001-0104-9","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}